Rinderon



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 13.3%
Malignant Glioma 13.3%
Threatened Labour 13.3%
Urinary Tract Infection 13.3%
Hypertension 6.7%
Malaise 6.7%
Maternal Therapy To Enhance Foetal Lung Maturity 6.7%
Meningioma 6.7%
Prostate Cancer 6.7%
Status Asthmaticus 6.7%
Uveitis 6.7%
Pulmonary Oedema 38.5%
Cytomegalovirus Enterocolitis 7.7%
Deep Vein Thrombosis 7.7%
Gastrointestinal Haemorrhage 7.7%
Glaucoma 7.7%
Malaise 7.7%
Osteonecrosis 7.7%
Secondary Adrenocortical Insufficiency 7.7%
Wheezing 7.7%
Secondary
Drug Use For Unknown Indication 33.7%
Rheumatoid Arthritis 10.0%
Prophylaxis 7.4%
Asthma 4.9%
Constipation 4.0%
Breast Cancer Metastatic 3.4%
Gastric Ulcer 3.3%
Pemphigoid 3.3%
Antiemetic Supportive Care 3.1%
Colon Cancer 3.1%
Drug Eruption 3.1%
Breast Cancer 2.8%
Hypertension 2.8%
Premedication 2.6%
Otitis Media Acute 2.5%
Rectal Cancer Metastatic 2.5%
Lung Neoplasm Malignant 2.0%
Anaplastic Astrocytoma 1.9%
Urinary Tract Infection 1.9%
Diabetes Mellitus 1.8%
Staphylococcal Infection 14.7%
White Blood Cell Count Decreased 9.5%
Proctitis Ulcerative 7.4%
Neutrophil Count Decreased 6.3%
Tongue Coated 6.3%
Hepatic Function Abnormal 5.3%
Interstitial Lung Disease 5.3%
Nausea 5.3%
Myocardial Ischaemia 4.2%
Shock 4.2%
Stevens-johnson Syndrome 4.2%
Transfusion-related Acute Lung Injury 4.2%
Treatment Noncompliance 4.2%
Gastrointestinal Haemorrhage 3.2%
Nasopharyngitis 3.2%
Pneumonia 3.2%
Urinary Tract Infection 3.2%
Dermatitis Bullous 2.1%
Lymphocyte Count Decreased 2.1%
Quadriplegia 2.1%
Concomitant
Prophylaxis 16.5%
Cancer Pain 10.9%
Drug Use For Unknown Indication 10.5%
Behcet's Syndrome 10.3%
Product Used For Unknown Indication 7.6%
Rheumatoid Arthritis 7.0%
Constipation 4.2%
Hypertension 3.9%
Metastatic Renal Cell Carcinoma 3.2%
Nausea 3.2%
Breast Cancer 2.6%
Insomnia 2.6%
Epilepsy 2.3%
Renal Cell Carcinoma 2.3%
Crohn's Disease 2.3%
Uveitis 2.3%
Asthma 2.1%
Prostate Cancer Stage Iv 2.1%
Gastritis 2.1%
Oedema 1.9%
White Blood Cell Count Decreased 15.1%
Vomiting 10.7%
Pyrexia 9.4%
Respiratory Failure 6.3%
Interstitial Lung Disease 6.0%
White Blood Cell Count Increased 5.7%
Platelet Count Decreased 5.0%
Pulmonary Embolism 4.1%
Stomatitis 4.1%
Renal Cell Carcinoma 3.8%
Pneumonia 3.5%
Wrong Technique In Drug Usage Process 3.5%
Liver Disorder 3.1%
Respiratory Arrest 3.1%
Weight Decreased 3.1%
Death 2.8%
Sepsis 2.8%
Urticaria 2.8%
Oral Pain 2.5%
Thrombocytopenia 2.5%